Genetic Modifiers and Rare Mendelian Disease
Despite advances in high-throughput sequencing that have revolutionized the discovery of gene defects in rare Mendelian diseases, there are still gaps in translating individual genome variation to observed phenotypic outcomes. While we continue to improve genomics approaches to identify primary dise...
Main Authors: | K. M. Tahsin Hassan Rahit, Maja Tarailo-Graovac |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/3/239 |
Similar Items
-
Strategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes
by: Eleanor G. Seaby, et al.
Published: (2021-06-01) -
Uncovering Missing Heritability in Rare Diseases
by: Tatiana Maroilley, et al.
Published: (2019-04-01) -
NCBoost classifies pathogenic non-coding variants in Mendelian diseases through supervised learning on purifying selection signals in humans
by: Barthélémy Caron, et al.
Published: (2019-02-01) -
PhenCards: a data resource linking human phenotype information to biomedical knowledge
by: James M. Havrilla, et al.
Published: (2021-05-01) -
Olfactory Malformations in Mendelian Disorders of the Epigenetic Machinery
by: Sebastiano Aleo, et al.
Published: (2020-08-01)